Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Relationship between Helicobacter pylori and Rosacea: review and discussion

Author: Xingzhe Yang

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Rosacea is an inflammatory disease affecting the central part of face characterized by persistent or recurrent episodes of erythema, papules, pustules and telangiectasias of unknown etiology. Helicobacter pylori (H. pylori) is a gram-negative bacillus, which is one of the main causes of chronic gastritis, gastric cancer and gastrointestinal ulcers. Recent evidences have suggested that H. pylori infection is closely related to the occurrence of diseases. In recent years, studies have found that Helicobacter pylori infection is associated with the occurrence of acne rosacea. So the treatment of Helicobacter pylori infection may be a therapeutic method of acne rosacea. But it continues to be controversial. In other studies, the treatment of Helicobacter pylori did not significantly reduce the severity of acne rosacea. To further explore the association between acne rosacea and Helicobacter pylori infection, a summarize method was used to study the relationship between acne rosacea and Helicobacter pylori, providing reference for clinical acne rosacea therapy.

Methods

Systematic searches were conducted on Wanfang Data, CQVIP, Springer, Public Health Management Corporation (PHMC), CNKI, and Pubmed, from January 1,2008 to Mar. 1, 2018, using Helicobacter pylori and rosacea to retrieve the literature. Depending on the inclusion and exclusion criteria, 27 articles considered or confirmed the correlation between H. pylori and rosacea.

Results

Epidemiological investigations and experiments have confirmed that H. pylori infection is associated with the development of rosacea. The effect of anti-H. pylori therapy is better than the routine therapy for rosacea. H. pylori can stimulate the immune system to produce a large number of inflammatory mediators, leading to the occurrence and aggravation of rosacea inflammation.

Conclusions

It is confirmed that H. pylori infection is involved in the development of rosacea. It is suggested that rosacea patients should be tested for H. pylori infection, the H. pylori-positive rosacea patients should be treated with eradication of H. pylori, so as to enhance the therapeutic effect of rosacea. This study adds that H. pylori infection is involved in the development of rosacea. Epidemiological investigations and experiments have confirmed the rationality. The effect of anti-H. pylori therapy is better than the routine therapy for rosacea. H. pylori-positive rosacea patients should be treated with the therapeutic method of eradication of H. pylori.
Literature
1.
go back to reference El-Khalawany M, Mahmoud A, Mosbeh AS, et al. Role of helicobacter pylori, in common rosacea subtypes: a geno-typic comparative study of Egyptian patients. Dermatol. 2012;39(12):989–95.CrossRef El-Khalawany M, Mahmoud A, Mosbeh AS, et al. Role of helicobacter pylori, in common rosacea subtypes: a geno-typic comparative study of Egyptian patients. Dermatol. 2012;39(12):989–95.CrossRef
2.
go back to reference Gravina AG, Federico A, Ruocco E, et al. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United European Gastroenterol J. 2015;3(1):17–24.CrossRefPubMedPubMedCentral Gravina AG, Federico A, Ruocco E, et al. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United European Gastroenterol J. 2015;3(1):17–24.CrossRefPubMedPubMedCentral
3.
go back to reference Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroim-mune aspects in the pathophysiology of rosacea. J Invest Dermatol. 2011;15:53–62.CrossRef Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroim-mune aspects in the pathophysiology of rosacea. J Invest Dermatol. 2011;15:53–62.CrossRef
6.
go back to reference Tan J, Schäfer H, Araviiskaia E, et al. Prevalence of rosacea in the general population of Germany and Russia-the RISE study. J Eur Acad Dermatol. 2016;30(3):428–34.CrossRef Tan J, Schäfer H, Araviiskaia E, et al. Prevalence of rosacea in the general population of Germany and Russia-the RISE study. J Eur Acad Dermatol. 2016;30(3):428–34.CrossRef
7.
go back to reference Gupta MA, Gupta AK, Chen SJ, et al. Comorbidity of rosacea and depression:an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the U.S.National Center for Health Statistics from 1995 to 2002. Brit J Dermatol. 2005;153(6):1176–81.CrossRef Gupta MA, Gupta AK, Chen SJ, et al. Comorbidity of rosacea and depression:an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the U.S.National Center for Health Statistics from 1995 to 2002. Brit J Dermatol. 2005;153(6):1176–81.CrossRef
9.
go back to reference Egeberg A, Weinstock LB, Thyssen EP, et al. Rosacea and gastrointestinal disorders: a population-based cohort study. Meier Br J Dermatol. 2017;176:9–10.CrossRef Egeberg A, Weinstock LB, Thyssen EP, et al. Rosacea and gastrointestinal disorders: a population-based cohort study. Meier Br J Dermatol. 2017;176:9–10.CrossRef
17.
go back to reference Szlachcic A. The link between helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol. 2002;16(4):328–33.CrossRefPubMed Szlachcic A. The link between helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol. 2002;16(4):328–33.CrossRefPubMed
18.
go back to reference Dundon WG, de Bernard M, Montecucco C. Virulence factors of helicobacter pylori. Int J Med Microbiol. 2001;290(8):647–58.CrossRefPubMed Dundon WG, de Bernard M, Montecucco C. Virulence factors of helicobacter pylori. Int J Med Microbiol. 2001;290(8):647–58.CrossRefPubMed
19.
go back to reference Bhattarai S, Agrawal S, Rijal A, et al. The study of prevalence of helicobacter pylori in patients with acne rosacea. Kathmandu Univ Med J. 2014;10(4):49–52.CrossRef Bhattarai S, Agrawal S, Rijal A, et al. The study of prevalence of helicobacter pylori in patients with acne rosacea. Kathmandu Univ Med J. 2014;10(4):49–52.CrossRef
26.
go back to reference Argenziano G, Donnarumma G, Iovene MR. Incidence of anti- helicobacter pylori and anti- CagA antibodies in rosacea patients. Int J Dermatol. 2003;42(8):601–4.CrossRefPubMed Argenziano G, Donnarumma G, Iovene MR. Incidence of anti- helicobacter pylori and anti- CagA antibodies in rosacea patients. Int J Dermatol. 2003;42(8):601–4.CrossRefPubMed
28.
go back to reference Drago F, De Col E, Agnoletti AF, et al. The role of small intesti-nal bacterial overgrowth in rosacea: a 3-year follow -up. J Am Acad Dermatol. 2016;75(3):e113–5.CrossRefPubMed Drago F, De Col E, Agnoletti AF, et al. The role of small intesti-nal bacterial overgrowth in rosacea: a 3-year follow -up. J Am Acad Dermatol. 2016;75(3):e113–5.CrossRefPubMed
Metadata
Title
Relationship between Helicobacter pylori and Rosacea: review and discussion
Author
Xingzhe Yang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3232-4

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue